Oxyphenonium

Oxyphenonium

SCHEMBL248890

CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.[Br-]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1CHRM3

The experimentally established mechanism targets of Oxyphenonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 4/20 0.98
CHRM3 known ✓ P20309 2/20 0.65
CHRM2 P08172 4/20 0.98
KCNH2 Q12809 3/20 0.98
SLC6A3 Q01959 2/20 0.98
LMNA P02545 2/20 0.66
CHRM4 P08173 2/20 0.65
POLB P06746 1/20 0.64
ALDH1A1 P00352 2/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
HTT P42858 1/20 0.57
CYP2C19 P33261 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
PKM P14618 1/20 0.56
NFKB1 P19838 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxyphenonium SCHEMBL250615 0.99 CHRM2 (1.00) CHRM2CHRM1KCNH2SLC6A3LMNA
Oxyphenonium SCHEMBL250614 0.99 CHRM2 (1.00) CHRM2CHRM1KCNH2SLC6A3LMNA
Oxyphenonium SCHEMBL2030870 0.98 CHRM2 (0.98) CHRM2CHRM1KCNH2SLC6A3LMNA
SCHEMBL23489737 0.90 CHRM2 (0.84) CHRM2CHRM1KCNH2SLC6A3LMNA
SCHEMBL2999990 0.88 CHRM2 (0.81) CHRM2CHRM1KCNH2SLC6A3LMNA
Hydrochloric Acid SCHEMBL29894890 0.88 CHRM2 (0.81) CHRM2CHRM1KCNH2SLC6A3LMNA
SCHEMBL13266147 0.84 POLB (0.76) CHRM2CHRM1KCNH2SLC6A3LMNA
SCHEMBL16887879 0.82 CHRM2 (0.71) CHRM2CHRM1KCNH2SLC6A3LMNA
SCHEMBL290176 0.81 CHRM2 (0.70) CHRM2CHRM1KCNH2SLC6A3LMNA
SCHEMBL13574067 0.81 CHRM2 (0.70) CHRM2CHRM1KCNH2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4467974-A1 NOVEL CHEMOSENSORS AND THEIR USE IN ELECTROCHEMICAL DETECTION METHODS Karlsruher Institut für Technologie (DE) 2024-11-27 EP claimed
EP-4419619-A1 SELECTIVE WET ETCH COMPOSITION AND METHOD Entegris, Inc. (US) 2024-08-28 EP claimed
US-11978622-B2 Aqueous and semi-aqueous cleaners for the removal of post-etch residues with tungsten and cobalt compatibility ENTEGRIS, INC. (US) 2024-05-07 US claimed
WO-2023069409-A1 SELECTIVE WET ETCH COMPOSITION AND METHOD ENTEGRIS, INC. (US) 2023-04-27 WO claimed
US-20230121639-A1 SELECTIVE WET ETCH COMPOSITION AND METHOD ENTEGRIS, INC. 2023-04-20 US claimed
CN-115605297-A Plasma coating treatment method for inhibiting transfer of biological pathogens 分子等离子集团股份有限公司(LU) 2023-01-13 CN claimed
CN-114401633-A Pest control method, pest control agent composition, and pest control agent set 日本曹达株式会社 2022-04-26 CN claimed
US-11124746-B2 Post CMP cleaning composition ENTEGRIS, INC. (US) 2021-09-21 US claimed
EP-2964725-B1 COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE ENTEGRIS INC (US) 2021-06-23 EP claimed
CN-110239944-B Ring main unit cabinet combining and inserting device and method 常州博瑞电力自动化设备有限公司 2021-05-11 CN claimed
EP-2026807-A1 USE OF PARASYMPATHOLYTIC SUBSTANCES TO ENHANCE AND ACCELERATE STEM CELL DIFFERENTIATION, RELATED METHOD AND COMPOSITIONS Universita' Degli Studi di Torino (IT) 2009-02-25 EP claimed
WO-2007135574-A1 USE OF PARASYMPATHOLYTIC SUBSTANCES TO ENHANCE AND ACCELERATE STEM CELL DIFFERENTIATION, RELATED METHOD AND COMPOSITIONS UNIVERSITA' DEGLI STUDI DI TORINO (IT) 2007-11-29 WO claimed
EP-1273301-B1 Pharmaceutical preparations based on active ingredients susceptible to illicit administration ALTERGON SA (CH) 2006-09-06 EP claimed
EP-1273301-A2 Pharmaceutical preparations based on active ingredients susceptible to illicit administration ALTERGON S.A. (CH) 2003-01-08 EP claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
EP-1072260-A1 Transdermal systems for the release of muscarinic receptor antagonists and use thereof for treatement of smooth muscle spasms in urology Novosis Pharma AG (DE) 2001-01-31 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
US-5008111-A Pretreating skin with anticholinergic quaternary ammonium salt to suppress perspiration SCHERING CORPORATION (US) 1991-04-16 US claimed
US-4824676-A ANTICHOLINERGIC AGENT TO SUPPRESS PERSPIRATION SCHERING CORPORATION (US) 1989-04-25 US claimed
EP-0140434-A2 Pharmaceutical composition with systemic anticholineesterasic, agonistic-cholinergic and antimuscarinic activity PRODOTTI FORMENTI S.r.l. (IT) 1985-05-08 EP claimed